Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 183

Similar articles for PubMed (Select 17687155)

1.

Time-dependent prognostic scoring system for predicting survival and leukemic evolution in myelodysplastic syndromes.

Malcovati L, Germing U, Kuendgen A, Della Porta MG, Pascutto C, Invernizzi R, Giagounidis A, Hildebrandt B, Bernasconi P, Knipp S, Strupp C, Lazzarino M, Aul C, Cazzola M.

J Clin Oncol. 2007 Aug 10;25(23):3503-10.

2.

Is International Prognostic Scoring System (IPSS) still standard in predicting prognosis in patients with myelodysplastic syndrome? External validation of the WHO Classification-Based Prognostic Scoring System (WPSS) and comparison with IPSS.

Park MJ, Kim HJ, Kim SH, Kim DH, Kim SJ, Jang JH, Kim K, Kim WS, Jung CW.

Eur J Haematol. 2008 Nov;81(5):364-73. doi: 10.1111/j.1600-0609.2008.01124.x. Epub 2008 Jul 10.

PMID:
18637029
3.

Classification and prognostic evaluation of myelodysplastic syndromes.

Cazzola M, Della Porta MG, Travaglino E, Malcovati L.

Semin Oncol. 2011 Oct;38(5):627-34. doi: 10.1053/j.seminoncol.2011.04.007. Review.

PMID:
21943669
4.

Prognostic classification and risk assessment in myelodysplastic syndromes.

Cazzola M, Malcovati L.

Hematol Oncol Clin North Am. 2010 Apr;24(2):459-68. doi: 10.1016/j.hoc.2010.02.005. Review.

PMID:
20359637
5.

Prognostic factors and life expectancy in myelodysplastic syndromes classified according to WHO criteria: a basis for clinical decision making.

Malcovati L, Porta MG, Pascutto C, Invernizzi R, Boni M, Travaglino E, Passamonti F, Arcaini L, Maffioli M, Bernasconi P, Lazzarino M, Cazzola M.

J Clin Oncol. 2005 Oct 20;23(30):7594-603. Epub 2005 Sep 26.

6.

Myelodysplastic syndromes: diagnosis and staging.

Malcovati L, Nimer SD.

Cancer Control. 2008 Oct;15 Suppl:4-13. Review.

7.

Detection of risk groups in myelodysplastic syndromes. A multicenter study.

Belli C, Acevedo S, Bengio R, Arrossagaray G, Watman N, Rossi N, García J, Flores G, Goldztein S, Larripa I.

Haematologica. 2002 Jan;87(1):9-16.

8.

The myelodysplastic syndromes: analysis of prognostic factors and comparison of prognostic systems in 128 Chinese patients from a single institution.

Zhao WL, Xu L, Wu W, Yan H, Tang W, Hu J, Chen Y, Li JM, Zeng XY, Xiong SM, Shen ZX, Chen Z, Wang ZY, Chen SJ.

Hematol J. 2002;3(3):137-44.

PMID:
12111649
9.

Impact of the degree of anemia on the outcome of patients with myelodysplastic syndrome and its integration into the WHO classification-based Prognostic Scoring System (WPSS).

Malcovati L, Della Porta MG, Strupp C, Ambaglio I, Kuendgen A, Nachtkamp K, Travaglino E, Invernizzi R, Pascutto C, Lazzarino M, Germing U, Cazzola M.

Haematologica. 2011 Oct;96(10):1433-40. doi: 10.3324/haematol.2011.044602. Epub 2011 Jun 9.

10.

Risk stratification based on both disease status and extra-hematologic comorbidities in patients with myelodysplastic syndrome.

Della Porta MG, Malcovati L, Strupp C, Ambaglio I, Kuendgen A, Zipperer E, Travaglino E, Invernizzi R, Pascutto C, Lazzarino M, Germing U, Cazzola M.

Haematologica. 2011 Mar;96(3):441-9. doi: 10.3324/haematol.2010.033506. Epub 2010 Dec 6.

11.

Clinical features of prognostic significance in myelodysplastic patients with normal karyotype at high risk of transformation.

Breccia M, Mancini M, Nanni M, D'Elia GM, Carmosino I, Latagliata R, Sarlo C, Mandelli F, Alimena G.

Leuk Res. 2005 Jan;29(1):33-9.

PMID:
15541472
12.

Comparisons of prognostic scoring systems for myelodysplastic syndromes: a Korean multicenter study.

Lee JJ, Kim HJ, Chung IJ, Kim JS, Sohn SK, Kim BS, Lee KH, Kwak JY, Park YH, Ahn JS, Park YS.

Leuk Res. 1999 May;23(5):425-32.

PMID:
10374856
13.
14.

Revised International Prognostic Scoring System (IPSS) predicts survival and leukemic evolution of myelodysplastic syndromes significantly better than IPSS and WHO Prognostic Scoring System: validation by the Gruppo Romano Mielodisplasie Italian Regional Database.

Voso MT, Fenu S, Latagliata R, Buccisano F, Piciocchi A, Aloe-Spiriti MA, Breccia M, Criscuolo M, Andriani A, Mancini S, Niscola P, Naso V, Nobile C, Piccioni AL, D'Andrea M, D'Addosio A, Leone G, Venditti A.

J Clin Oncol. 2013 Jul 20;31(21):2671-7. doi: 10.1200/JCO.2012.48.0764. Epub 2013 Jun 24.

15.

Refractory cytopenia with unilineage dysplasia: analysis of prognostic factors and survival in 126 patients.

Breccia M, Latagliata R, Cannella L, Carmosino I, Santopietro M, Loglisci G, Federico V, Alimena G.

Leuk Lymphoma. 2010 May;51(5):783-8. doi: 10.3109/10428191003682759.

PMID:
20302387
16.

Clinical relevance of bone marrow fibrosis and CD34-positive cell clusters in primary myelodysplastic syndromes.

Della Porta MG, Malcovati L, Boveri E, Travaglino E, Pietra D, Pascutto C, Passamonti F, Invernizzi R, Castello A, Magrini U, Lazzarino M, Cazzola M.

J Clin Oncol. 2009 Feb 10;27(5):754-62. doi: 10.1200/JCO.2008.18.2246. Epub 2008 Dec 22.

17.

[Myelodysplastic syndrome--classification, prognosis and therapy].

Cermák J, Michalová K, Vítek A.

Cas Lek Cesk. 2002 Sep 22;141 Suppl:33-7. Czech.

PMID:
12428420
18.
19.

[Prognostic potential of morphological and cytogenetic indices in patients with myelodysplastic syndrome].

Gritsaev SV, Martynkevich IS, Abdulkadyrov KM, Tiranova SA, Kakaĭ MP, Martynenko LS, Dziavgo LA.

Ter Arkh. 2005;77(7):22-7. Russian.

PMID:
16116904
20.

Classification and scoring systems in myelodysplastic syndromes: a retrospective analysis of 311 patients.

Navarro I, Ruiz MA, Cabello A, Collado R, Ferrer R, Hueso J, Martinez J, Miguel A, Orero MT, Pérez P, Nolasco A, Carbonell F.

Leuk Res. 2006 Aug;30(8):971-7. Epub 2006 Jan 19.

PMID:
16423393
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk